Providing Doctor-Approved Medicines & Developing Drugs for Unmet Medical Needs
Synageva is a biopharmaceutical company given to the discovery and development of medicines for patients with rare diseases. We take responsibility for and commit to the health and well-being of patients.
Hence, we ensure strict adherence to policies with our research.
Numerous studies and research carried out have set a precedent for the development of new orphan drugs. Biopharmaceuticals, as the name implies, are biologically sourced. Since they're usually large molecule proteins and nucleic acids, developing them follows a strict...
Scientists usually isolate active principles or compounds from natural products for the formation of drugs. However, biopharmaceutical formulations differ slightly from generic pharmaceuticals. That's because they're heterogeneous mixtures with large molecular...
Presently, the concept of essential medicines prevails in the healthcare industry. Therefore, it's inevitable that patients with conditions don't ail the majority of the population get left out. This issue is paramount and is gaining traction as governments enact...
Muscle pain is one of the most common types of pain. It can range from feeling light aches to severe, sharp pains that last for a long period of time. Most people experience muscle pain at some point in their lives, and there are many ways to treat it. It can be...
It’s no news that the pharmaceutical industry is one of the fastest-growing in the world. Due to its sensitive nature and the massive responsibilities that come with being a much-needed and precious sector, the need to maintain top-functionality in every domain is...
5 Routes to Safe Medication Administration Medical errors stand as the third leading cause of death in the United States of America after cancer and heart diseases, claiming about 250 000 lives yearly. The errors include delayed and misdiagnosis, medication error,...
Developing New Medicines
Numerous studies and research carried out have set a precedent for the development of new orphan drugs. Biopharmaceuticals, as the name implies, are biologically sourced. Since they’re usually large molecule proteins and nucleic acids, developing them follows a strict process. Examples include recombinant proteins and monoclonal antibodies, such as those used in cancer treatments.
150 Lincoln Street
Laurel Springs, NJ 08021
M-F: 8am – 5pm
S-S: 9am – 4pm